Accendra Health, Inc.

ACH

CIK 0000075252 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$709M
Operating Income
$990K
Gross Profit
$323M

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
30/100
  • Profitability
    100ROIC 34.6% (10% = solid, 20%+ = moat)
  • Liquidity
    4Current Ratio 0.58 (above 1.5 = solid)
  • Leverage
    28D/E 1.44 (under 0.5 = conservative)
  • Efficiency
    44Asset Turnover 0.78x (1.0+ = capital-efficient)
  • Growth
    0Insufficient data
  • Margin Trend
    1Op Margin 0.1% · trend -3.0pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$67M
investment in PP&E
Dividends paid (TTM)
cash returned to holders
Stock buybacks (TTM)
$10M
share count reduction
Stock-based comp (TTM)
$17M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$2.45B
everything owned
Total liabilities
$2.91B
everything owed
Stockholders' equity
$-461M
shareholder claim
Net debt
$744M
LT debt minus cash

Recent performance · 67 quarters

Revenue
$709M
Net Income↓-1076.8% -$138M
$-150M
Free Cash Flow↑+40.1% +$9M
$-13M
Operating Margin
0.1%

Drill down